Tiny Health raises $33M Series B for gut microbiome testing
- Company
- Tiny Health
- Funding stage
- Series B
- Amount
- $33 million
- Date
- Location
- 🇺🇸 Austin, the US
- Sector
- Microbiome Testing
- Investors
- B Capital
What happened
Austin-based Tiny Health secured $33 million in Series B funding led by B Capital. The round will support growing demand for at-home microbiome testing.
Why it matters
B Capital's participation signals growth-stage conviction in direct-to-consumer diagnostics expanding beyond basic wellness into actionable health tracking. Tiny Health's expansion shows that gut health testing is gaining traction as part of preventative pediatric and family medicine.
What to watch
Distribution expansion through pediatrician networks and clinical partnerships alongside direct consumer sales.
VCBites Signal
Why this score: A $33M Series B led by a tier-one growth investor reflects strong unit economics and sustained consumer demand in the healthtech sector.
VCBites' internal significance rating (0-100) — our editorial read, not a market-standard metric. VC Bites' assessment of the significance of this development to the venture ecosystem. Not investment advice.
Who should care?
- Healthtech Founders
- Growth Investors
- Consumer Health
- Digital Health
Source
This is an original short summary. Read the full reporting at the original source.
Read the original story on Crunchbase NewsShare the signal
VC Bites
Tiny Health raises $33M Series B for gut microbiome testing
VCBITES SIGNAL: 53 / 100
Why it matters
B Capital's participation signals growth-stage conviction in direct-to-consumer diagnostics expanding beyond basic wellness into actionable health tracking. Tiny Health's expansion shows that gut health testing is gaining traction as part of preventative pediatric and family medicine.
VC Bites · Venture capital signals, explained.
The post text is copied to your clipboard so you can paste it alongside the link.